Weight Watchers' Shift

Weight Watchers is pivoting its business model, potentially embracing the sale of semaglutide products to enhance its weight loss offerings. With a substantial subscriber base, the company aims to guarantee weight loss through a blend of behavioral and clinical approaches. The CEO emphasizes the company's strong financial position and commitment to growth amidst changing market dynamics.